Skip to main content
. 2020 Oct 30;99(44):e22892. doi: 10.1097/MD.0000000000022892

Figure 5.

Figure 5

Serum levels of sTIM-3 were compared between RA patients with or without DAS28-ESR clinical remission (A) or those with or without advanced joint damage (B). A; Serum sTIM-3 were significantly lower in RA patients with CR compared to those without CR. CR = clinical remission. B: Serum sTIM-3 were significantly higher in RA patients with advance joint damage (stage III or IV) compared to those without advance joint damage. RA = rheumatoid arthritis, sTIM-3 = soluble T cell immunoglobulin domain and mucin-3.